215 related articles for article (PubMed ID: 22774260)
1. Combination therapy no advantage in Alzheimer's treatment.
Harv Health Lett; 2012 Jun; 37(8):8. PubMed ID: 22774260
[No Abstract] [Full Text] [Related]
2. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
[No Abstract] [Full Text] [Related]
3. Alzheimer Disease: Monotherapy vs. Combination Therapy.
Lawler E; Avila A
Am Fam Physician; 2017 Apr; 95(7):452. PubMed ID: 28409590
[No Abstract] [Full Text] [Related]
4. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
5. [Use of acetylcholinesterase inhibitors and memantine in Alzheimer-type dementia].
Portela Romero M; Pombo Romero J; Bugarín González R; Tasende Souto M; Represa Veiga S
Rev Esp Salud Publica; 2005; 79(6):665-72. PubMed ID: 16457058
[TBL] [Abstract][Full Text] [Related]
6. [Are anti-dementia drugs worthwhile?].
Lang CJ
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():85-9. PubMed ID: 17955784
[TBL] [Abstract][Full Text] [Related]
7. Memantine for treatment of moderate to severe Alzheimer's disease.
Perras C
Issues Emerg Health Technol; 2005 Mar; (64):1-4. PubMed ID: 15762015
[TBL] [Abstract][Full Text] [Related]
8. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease.
Gauthier S; Molinuevo JL
Alzheimers Dement; 2013 May; 9(3):326-31. PubMed ID: 23110864
[TBL] [Abstract][Full Text] [Related]
9. Use of memantine for the treatment of dementia.
Lo D; Grossberg GT
Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
[TBL] [Abstract][Full Text] [Related]
10. Memantine: new preparation. Poor evaluation and uncertain benefit in Alzheimer's disease.
Prescrire Int; 2003 Dec; 12(68):203-5. PubMed ID: 14986682
[TBL] [Abstract][Full Text] [Related]
11. Memantine for patients with Alzheimer disease.
Finucane TE
JAMA; 2004 Apr; 291(14):1695; author reply 1695. PubMed ID: 15082684
[No Abstract] [Full Text] [Related]
12. Pharmacologic management of Alzheimer disease.
Downey D
J Neurosci Nurs; 2008 Feb; 40(1):55-9. PubMed ID: 18330411
[TBL] [Abstract][Full Text] [Related]
13. [Current strategies of pathogenetic therapy of Alzheimer's disease].
Gavrilova SI; Zharikov GA
Vestn Ross Akad Med Nauk; 2001; (7):13-8. PubMed ID: 11523421
[TBL] [Abstract][Full Text] [Related]
14. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.
Feldman HH; Schmitt FA; Olin JT;
Alzheimer Dis Assoc Disord; 2006; 20(4):263-8. PubMed ID: 17132971
[TBL] [Abstract][Full Text] [Related]
15. Namzaric--a combination of 2 old drugs for Alzheimer's disease.
Med Lett Drugs Ther; 2015 Jul; 57(1473):105-6. PubMed ID: 26204041
[No Abstract] [Full Text] [Related]
16. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
Riordan KC; Hoffman Snyder CR; Wellik KE; Caselli RJ; Wingerchuk DM; Demaerschalk BM
Neurologist; 2011 Mar; 17(2):121-3. PubMed ID: 21364371
[TBL] [Abstract][Full Text] [Related]
18. A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study.
Arai H; Takahashi T
Am J Geriatr Psychiatry; 2009 Apr; 17(4):353-4. PubMed ID: 19307864
[No Abstract] [Full Text] [Related]
19. Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study.
Matsuzono K; Hishikawa N; Ohta Y; Yamashita T; Deguchi K; Nakano Y; Abe K
J Alzheimers Dis; 2015; 45(3):771-80. PubMed ID: 25624417
[TBL] [Abstract][Full Text] [Related]
20. A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil.
van Dyck CH; Schmitt FA; Olin JT;
Am J Geriatr Psychiatry; 2006 May; 14(5):428-37. PubMed ID: 16670247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]